451 related articles for article (PubMed ID: 28771838)
21. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-12 modulates the immunomodulatory properties of human periodontal ligament cells.
Issaranggun Na Ayuthaya B; Satravaha P; Pavasant P
J Periodontal Res; 2017 Jun; 52(3):546-555. PubMed ID: 27663623
[TBL] [Abstract][Full Text] [Related]
23. [Indoleamine 2, 3-dioxygenase activity in acute myeloid leukemia cells contributing to tumor immune escape].
Tang XQ; Zhao ZG; Wang HX; Li QB; Lü J; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):539-42. PubMed ID: 16800938
[TBL] [Abstract][Full Text] [Related]
24. Temperature-sensitive polymer-conjugated IFN-gamma induces the expression of IDO mRNA and activity by fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Uludag H; Kilani RT; Karami A; Li Y; Iwashina T; Ghahary A
J Cell Physiol; 2004 Oct; 201(1):146-54. PubMed ID: 15281097
[TBL] [Abstract][Full Text] [Related]
25. Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity.
Zhang Z; Han Y; Song J; Luo R; Jin X; Mu D; Su S; Ji X; Ren YF; Liu H
J Oral Pathol Med; 2015 Jan; 44(1):15-27. PubMed ID: 25212102
[TBL] [Abstract][Full Text] [Related]
26. Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.
Colvin BL; Sumpter TL; Tokita D; Salati J; Mellor AL; Thomson AW
Hum Immunol; 2009 May; 70(5):313-20. PubMed ID: 19208362
[TBL] [Abstract][Full Text] [Related]
27. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
[TBL] [Abstract][Full Text] [Related]
28. Monocytic suppressor cells derived from human peripheral blood suppress xenogenic immune reactions.
Maeda A; Kawamura T; Ueno T; Usui N; Miyagawa S
Xenotransplantation; 2014; 21(1):46-56. PubMed ID: 24372857
[TBL] [Abstract][Full Text] [Related]
29. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
[TBL] [Abstract][Full Text] [Related]
30. Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism.
Joo YD; Lee SM; Lee SW; Lee WS; Lee SM; Park JK; Choi IW; Park SG; Choi I; Seo SK
Immunology; 2009 Sep; 128(1 Suppl):e632-40. PubMed ID: 19740324
[TBL] [Abstract][Full Text] [Related]
31. Human amniotic fluid stem cells suppress PBMC proliferation through IDO and IL-10-dependent pathways.
Luo C; Jia W; Wang K; Chi F; Gu Y; Yan X; Zou G; Duan T; Zhou Q
Curr Stem Cell Res Ther; 2014 Jan; 9(1):36-45. PubMed ID: 24102581
[TBL] [Abstract][Full Text] [Related]
32. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression.
Yuan W; Collado-Hidalgo A; Yufit T; Taylor M; Varga J
J Cell Physiol; 1998 Oct; 177(1):174-86. PubMed ID: 9731757
[TBL] [Abstract][Full Text] [Related]
33. Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?
Löb S; Ebner S; Wagner S; Weinreich J; Schäfer R; Königsrainer A
Transplantation; 2007 Feb; 83(4):468-73. PubMed ID: 17318080
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1.
Hissong BD; Byrne GI; Padilla ML; Carlin JM
Cell Immunol; 1995 Feb; 160(2):264-9. PubMed ID: 7720088
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of interferon-mediated inhibition of Chlamydia infection by interleukin-1 in human macrophage cultures.
Carlin JM; Weller JB
Infect Immun; 1995 May; 63(5):1870-5. PubMed ID: 7537250
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells.
Alberati-Giani D; Malherbe P; Ricciardi-Castagnoli P; Köhler C; Denis-Donini S; Cesura AM
J Immunol; 1997 Jul; 159(1):419-26. PubMed ID: 9200481
[TBL] [Abstract][Full Text] [Related]
37. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.
Han Y; Chen Z; Yang Y; Jiang Z; Gu Y; Liu Y; Lin C; Pan Z; Yu Y; Jiang M; Zhou W; Cao X
Hepatology; 2014 Feb; 59(2):567-79. PubMed ID: 23960017
[TBL] [Abstract][Full Text] [Related]
38. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
[TBL] [Abstract][Full Text] [Related]
39. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells.
Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC
Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283
[TBL] [Abstract][Full Text] [Related]
40. Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells.
Schroecksnadel S; Sucher R; Kurz K; Fuchs D; Brandacher G
Transpl Immunol; 2011 Sep; 25(2-3):119-23. PubMed ID: 21742032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
